MRNA
Moderna Inc
Price:  
24.71 
USD
Volume:  
6,677,417.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MRNA EV/EBITDA

-407.2%
Upside

As of 2025-04-21, the EV/EBITDA ratio of Moderna Inc (MRNA) is -2.32. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRNA's latest enterprise value is 7,690.31 mil USD. MRNA's TTM EBITDA according to its financial statements is -3,312.00 mil USD. Dividing these 2 quantities gives us the above MRNA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 9.3x - 13.4x 11.0x
Forward P/E multiples 6.9x - 9.7x 7.8x
Fair Price (75.19) - (78.44) (75.92)
Upside -404.2% - -417.4% -407.2%
24.71 USD
Stock Price
(75.92) USD
Fair Price

MRNA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-04-17 -2.32
2025-04-16 -2.38
2025-04-15 -2.50
2025-04-14 -2.57
2025-04-11 -2.50
2025-04-10 -2.30
2025-04-09 -2.55
2025-04-08 -2.31
2025-04-07 -2.43
2025-04-04 -2.37
2025-04-03 -2.44
2025-04-02 -2.67
2025-04-01 -2.61
2025-03-31 -2.75
2025-03-28 -3.07
2025-03-27 -3.19
2025-03-26 -3.11
2025-03-25 -3.39
2025-03-24 -3.43
2025-03-21 -3.25
2025-03-20 -3.22
2025-03-19 -3.33
2025-03-18 -3.38
2025-03-17 -3.49
2025-03-14 -3.48
2025-03-13 -3.44
2025-03-12 -3.52
2025-03-11 -3.38
2025-03-10 -3.63
2025-03-07 -3.59
2025-03-06 -3.44
2025-03-05 -3.55
2025-03-04 -2.98
2025-03-03 -2.97
2025-02-28 -3.05
2025-02-27 -3.07
2025-02-26 -3.36
2025-02-25 -3.32
2025-02-24 -3.39
2025-02-21 -3.58
2025-02-20 -3.37
2025-02-19 -3.63
2025-02-18 -3.61
2025-02-14 -3.29
2025-02-13 -3.16
2025-02-12 -3.00
2025-02-11 -3.05
2025-02-10 -3.16
2025-02-07 -3.24
2025-02-06 -3.36